One-year results of bioresorbable vascular scaffolds for coronary chronic total occlusions

American Journal of Cardiology

Volumn 117, Issue 6, 2016, Pages 906-917

  Vaquerizo, Beatriz ^a,b   Barros, Antonio ^a   Pujadas, Sandra ^a   Bajo, Ester ^a   Jiménez, Marcelo ^a   Gomez Lara, José ^c   Jacobi, Francisco ^c   Salvatella, Neus ^b   Pons, Guillem ^a   Cinca, Juan ^a   Serra, Antonio ^a  

^a Hospital Sant Pau   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICAGRELOR; CARDIOVASCULAR AGENT; EVEROLIMUS;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BIORESORBABLE SCAFFOLD; BIORESORBABLE VASCULAR SCAFFOLD; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; CORONARY CHRONIC TOTAL OCCLUSION; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; MULTIDETECTOR COMPUTED TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIGHT CORONARY ARTERY; AGED; ANGIOGRAPHY; CHRONIC DISEASE; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG ELUTING STENT; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; SENSITIVITY AND SPECIFICITY; SPAIN; TISSUE SCAFFOLD; TREATMENT OUTCOME;

AGED; ANGIOGRAPHY; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; EVEROLIMUS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPAIN; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84959540232     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.12.025     Document Type: Review

References (27)

1. G. Niccoli, A. Leo, S. Giubilato, N. Cosentino, S. Minelli, V.A. Galiffa, and F. Crea Drug eluting stent and coronary chronic total occlusions Minerva Cardioangiol 59 2011 271 284
2. M.K. Hong, G.S. Mintz, C.W. Lee, D.W. Park, K.M. Park, B.K. Lee, Y.H. Kim, J.M. Song, K.H. Han, D.H. Kang, S.S. Cheong, J.K. Song, J.J. Kim, S.W. Park, and S.J. Park Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up Circulation 113 2006 414 419
3. B.D. Gogas, P.W. Serruys, R. Diletti, V. Farooq, S. Brugaletta, M.D. Radu, J.H. Heo, Y. Onuma, R.J. van Geuns, E. Regar, B. De Bruyne, B. Chevalier, L. Thuesen, P.C. Smits, D. Dudek, J. Koolen, S. Windecker, R. Whitbourn, K. Miquel-Hebert, C. Dorange, R. Rapoza, H.M. Garcia-Garcia, D. McClean, and J.A. Ormiston Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial JACC Cardiovasc Interv 5 2012 656 665
4. P.W. Serruys, Y. Onuma, H.M. Garcia-Garcia, T. Muramatsu, R.J. van Geuns, B. de Bruyne, D. Dudek, L. Thuesen, P.C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K.M. Hebert, R. Rapoza, and J.A. Ormiston Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months EuroIntervention 9 2014 1271 1284
5. S. Nakatani, Y. Onuma, Y. Ishibashi, T. Muramatsu, J. Iqbal, Y.J. Zhang, R.J. van Geuns, J.A. Ormiston, and P.W. Serruys Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial EuroIntervention 10 2015 1288 1298
6. A. Karanasos, C. Simsek, M. Gnanadesigan, N.S. van Ditzhuijzen, R. Freire, J. Dijkstra, S. Tu, N. Van Mieghem, G. van Soest, P. de Jaegere, P.W. Serruys, F. Zijlstra, R.J. van Geuns, and E. Regar OCT assessment of the long-term vascular healing response 5 Years After everolimus-eluting bioresorbable vascular scaffold J Am Coll Cardiol 64 2014 2343 2356
7. T. Palmerini, G. Biondi-Zoccai, D. Della Riva, A. Mariani, M. Sabate, P.C. Smits, C. Kaiser, F. D'Ascenzo, G. Frati, M. Mancone, P. Genereux, and G.W. Stone Clinical outcomes with bioabsorbable polymer-versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis J Am Coll Cardiol 63 2014 299 307
8. S.G. Ellis, D.J. Kereiakes, D.C. Metzger, R.P. Caputo, D.G. Rizik, P.S. Teirstein, M.R. Litt, A. Kini, A. Kabour, S.O. Marx, J.J. Popma, R. McGreevy, Z. Zhang, C. Simonton, G.W. Stone ABSORB III Investigators Everolimus-eluting bioresorbable scaffolds for coronary artery disease N Engl J Med 373 2015 1905 1915
9. P.W. Serruys, B. Chevalier, D. Dudek, A. Cequier, D. Carrié, A. Iniguez, M. Dominici, R.J. van der Schaaf, M. Haude, L. Wasungu, S. Veldhof, L. Peng, P. Staehr, M.J. Grundeken, Y. Ishibashi, H.M. Garcia-Garcia, and Y. Onuma A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Lancet 385 2015 43 54
10. B. Vaquerizo, A. Barros, S. Pujadas, E. Bajo, D. Estrada, F. Miranda-Guardiola, J. Rigla, M. Jiménez, J. Cinca, and A. Serra Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study EuroIntervention 11 2015 555 563
11. J. Wiebe, C. Liebetrau, O. Dörr, A. Most, K. Weipert, J. Rixe, T. Bauer, H. Möllmann, A. Elsässer, C.W. Hamm, and H.M. Nef Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion Int J Cardiol 179 2015 90 94
12. C. Di Mario, G.S. Werner, G. Sianos, A.R. Galassi, J. Büttner, D. Dudek, B. Chevalier, T. Lefevre, J. Schofer, J. Koolen, H. Sievert, B. Reimers, J. Fajadet, A. Colombo, A. Gershlick, P.W. Serruys, and N. Reifart European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club EuroIntervention 3 2007 30 43
13. D. Capodanno, T. Gori, H. Nef, A. Latib, J. Mehilli, M. Lesiak, G. Caramanno, C. Naber, C. Di Mario, A. Colombo, P. Capranzano, J. Wiebe, A. Araszkiewicz, S. Geraci, S. Pyxaras, A. Mattesini, T. Naganuma, T. Münzel, and C. Tamburino Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry EuroIntervention 10 2015 1144 1153
14. J. Gomez-Lara, L. Teruel, S. Homs, J.L. Ferreiro, R. Romaguera, G. Roura, G. Sánchez-Elvira, F. Jara, S. Brugaletta, J.A. Gomez-Hospital, and A. Cequier Lumen enlargement of the coronary segments located distal to chronic total occlusions successfully treated with drug-eluting stents at follow-up EuroIntervention 9 2014 1181 1188
15. P.W. Serruys, Y. Onuma, D. Dudek, P.C. Smits, J. Koolen, B. Chevalier, B. de Bruyne, L. Thuesen, D. McClean, R.J. van Geuns, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K.M. Hebert, K. Sudhir, H.M. Garcia-Garcia, and J.A. Ormiston Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes J Am Coll Cardiol 58 2011 1578 1588
16. Y. Onuma, D. Dudek, L. Thuesen, M. Webster, K. Nieman, H.M. Garcia-Garcia, J.A. Ormiston, and P.W. Serruys Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease. The ABSORB cohort a trial JACC Cardiovasc Interv 6 2013 999 1009
17. P.W. Serruys, J.A. Ormiston, Y. Onuma, E. Regar, N. Gonzalo, H.M. Garcia-Garcia, K. Nieman, N. Bruining, C. Dorange, K. Miquel-Hébert, S. Veldhof, M. Webster, L. Thuesen, and D. Dudek A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
18. Y. Morino, M. Abe, T. Morimoto, T. Kimura, Y. Hayashi, T. Muramatsu, M. Ochiai, Y. Noguchi, K. Kato, Y. Shibata, Y. Hiasa, O. Doi, T. Yamashita, T. Hinohara, H. Tanaka, K. Mitsudo J-CTO Registry Investigators Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool JACC Cardiovasc Interv 4 2011 213 221
19. Y.J. Zhang, J. Iqbal, S. Nakatani, C.V. Bourantas, C.M. Campos, Y. Ishibashi, Y.K. Cho, S. Veldhof, J. Wang, Y. Onuma, H.M. Garcia-Garcia, D. Dudek, R.J. van Geuns, P.W. Serruys ABSORB Cohort B Study Investigators Scaffold and edge vascular response following implantation of everolimus-eluting bioresorbable vascular scaffold: a 3-year serial optical coherence tomography study JACC Cardiovasc Interv 7 2014 1361 1369
20. R.P. Kraak, M.E. Hassell, M.J. Grundeken, K.T. Koch, J.P. Henriques, J.J. Piek, J. Baan Jr., M.M. Vis, E.K. Arkenbout, J.G. Tijssen, R.J. de Winter, and J.J. Wykrzykowska Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry EuroIntervention 10 2015 1160 1168
21. S. Ojeda, M. Pan, M. Romero, J. Suárez de Lezo, F. Mazuelos, J. Segura, S. Espejo, C. Morenate, M. Blanco, P. Martín, A. Medina, and J. Suárez de Lezo Outcomes and computed tomography scan follow-up of bioresorbable vascular scaffold for the percutaneous treatment of chronic total coronary artery occlusion Am J Cardiol 115 2015 1487 1493
22. H.J. Park, H.Y. Kim, J.M. Lee, Y.S. Choi, C.S. Park, D.B. Kim, S.H. Her, Y.S. Koh, M.W. Park, B.J. Kwon, P.J. Kim, K. Chang, W.S. Chung, and K.B. Seung Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion - CAtholic Total Occlusion Study (CATOS) trial Circ J 76 2012 868 875
23. A.R. Galassi, S.D. Tomasello, L. Costanzo, M.B. Campisano, G. Barrano, and C. Tamburino Long-term clinical and angiographic results of sirolimus-eluting stent in complex coronary chronic total occlusion revascularization: the SECTOR registry J Interv Cardiol 24 2011 426 436
24. R. Valenti, R. Vergara, A. Migliorini, G. Parodi, N. Carrabba, G. Cerisano, E.V. Dovellini, and D. Antoniucci Predictors of reocclusion after successful drug- eluting stent-supported percutaneous coronary intervention of chronic total occlusion J Am Coll Cardiol 61 2013 545 550
25. R. Diletti, V. Farooq, C. Girasis, C. Bourantas, Y. Onuma, J.H. Heo, B.D. Gogas, R.J. van Geuns, E. Regar, B. de Bruyne, D. Dudek, L. Thuesen, B. Chevalier, D. McClean, S. Windecker, R.J. Whitbourn, P. Smits, J. Koolen, I. Meredith, X. Li, K. Miquel-Hebert, S. Veldhof, H.M. Garcia-Garcia, J.A. Ormiston, and P.W. Serruys Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial Heart 99 2013 98 105
26. J.M. De la Torre Hernandez Late acquired incomplete stent apposition: incidence, mechanisms and clinical implications EuroIntervention 5 2009 D112 D120 Review
27. A.K. Hassan, S.C. Bergheanu, T. Stijnen, B.L. van der Hoeven, J.D. Snoep, J.W. Plevier, M.J. Schalij, and J. Wouter Jukema Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis Eur Heart J 31 2010 1172 1180